JP2020058297A - Creatine-containing water dispersible powdery composition and method for producing the same - Google Patents

Creatine-containing water dispersible powdery composition and method for producing the same Download PDF

Info

Publication number
JP2020058297A
JP2020058297A JP2018192372A JP2018192372A JP2020058297A JP 2020058297 A JP2020058297 A JP 2020058297A JP 2018192372 A JP2018192372 A JP 2018192372A JP 2018192372 A JP2018192372 A JP 2018192372A JP 2020058297 A JP2020058297 A JP 2020058297A
Authority
JP
Japan
Prior art keywords
creatine
water
emulsifier
powdery composition
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018192372A
Other languages
Japanese (ja)
Other versions
JP7089278B2 (en
Inventor
諒平 小林
Ryohei Kobayashi
諒平 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yokohama Oils and Fats Industry Co Ltd
Original Assignee
Yokohama Oils and Fats Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yokohama Oils and Fats Industry Co Ltd filed Critical Yokohama Oils and Fats Industry Co Ltd
Priority to JP2018192372A priority Critical patent/JP7089278B2/en
Publication of JP2020058297A publication Critical patent/JP2020058297A/en
Application granted granted Critical
Publication of JP7089278B2 publication Critical patent/JP7089278B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

To provide a creatine-containing water dispersible powdery composition in which the water dispersibility of creatine is good and which can be provided in a dosage form that is difficult to provide in the prior art, namely, in a form of beverage and powdered beverage and thus providing a high convenience when used as a supplement, and a method for producing the same.SOLUTION: Provided is a creatine-containing water dispersible powdery composition which contains an emulsifier by 0.1 to 10 pts.wt. for 100 pts.mass of creatine and in which a part or all of the surface of creatine is covered with the emulsifier.SELECTED DRAWING: None

Description

本発明は、クレアチンの水分散性を改善し、摂取効率を高めた、クレアチン含有水分散性粉末状組成物及びその製造方法に関する。   The present invention relates to a creatine-containing water-dispersible powdery composition having improved creatine water dispersibility and increased ingestion efficiency, and a method for producing the same.

クレアチンは生体内においてATPの再合成に関わる物質であり、摂取によって運動パフォーマンスの増加をもたらしたとされる報告が多数上がっている。また筋肉を増強する効果についても示唆されており、実際に多くのアスリートが摂取しているなど、知名度も高い。   Creatine is a substance involved in ATP resynthesis in the living body, and there are many reports that creatine causes an increase in exercise performance when ingested. It has also been suggested to have an effect of strengthening muscles, and it is well known as being actually taken by many athletes.

クレアチンは生体内でも合成される物質であり、また肉や魚に比較的多く含まれる(5g/1kg)。ただし、前述のような効果を発揮するには多量の摂取(20g/日)が必要とされ、これを食事のみで摂取しようとすると栄養バランスの乱れに繋がる。よって、クレアチンをサプリメントとして経口摂取する方法が注目されている。しかし、クレアチンを結晶体としてそのまま直接摂取すると、砂的なザラザラした食感があるため、経口摂取しやすいとはいえない。   Creatine is a substance that is synthesized in vivo and is contained in a relatively large amount in meat and fish (5 g / 1 kg). However, a large amount of intake (20 g / day) is required to exert the above-mentioned effects, and if this is ingested only with food, the nutritional balance will be disturbed. Therefore, a method of orally ingesting creatine as a supplement has attracted attention. However, if creatine is directly ingested as a crystal as it is, it cannot be said to be easily ingested orally because it has a gritty texture.

そこで、クレアチンをそのまま摂取するのではなく、飲料に溶解して摂取することが考えられる。しかし、クレアチンは水、油に難溶性の物質であり(溶解度は約10g/L、10℃水)、飲料へ添加しても十分な量が溶解せず、また、クレアチンを添加した飲料(酸性のものが多い)の保存中にクレアチンが析出する可能性もある。   Therefore, it is considered that creatine is not taken as it is but is dissolved in a drink and taken. However, creatine is a substance that is sparingly soluble in water and oil (solubility is about 10 g / L, 10 ° C water), and a sufficient amount of creatine cannot be dissolved even when added to a beverage. Creatine may precipitate during storage.

さらに、酸性下では特に、クレアチンはクレアチニンへの構造変化を起こしやすく、その結果、運動パフォーマンスの向上効果をもたらさない物質となってしまう。そのため、前もって、クレアチン含有の酸性飲料を調製しておくと、時間の経過により、クレアチンがクレアチニンに変化してしまい、クレアチンの効果を享受することができなくなる恐れがある。すなわち、クレアチン含有の酸性飲料は、クレアチンの効果という点でいえば、長期間の保存には適していない。   Furthermore, especially under acidic conditions, creatine is apt to undergo a structural change to creatinine, and as a result, it becomes a substance that does not bring about the effect of improving exercise performance. Therefore, if an acidic beverage containing creatine is prepared in advance, creatine may change to creatinine over time, and the effect of creatine may not be enjoyed. That is, the creatine-containing acidic beverage is not suitable for long-term storage in terms of the effect of creatine.

そこで、粉末飲料として、飲用する直前にクレアチンを水に加えて、クレアチンの水溶液を調製し、これを飲用することで、クレアチンを摂取する方法が考えられる。この方法であると、クレアチンを水に加えてから摂取するまでの時間経過が少ないため、クレアチンからクレアチニンへの変化を心配する必要はない。   Therefore, as a powdered beverage, a method of ingesting creatine by adding creatine to water immediately before drinking to prepare an aqueous solution of creatine, and drinking this can be considered. With this method, it is not necessary to worry about the change from creatine to creatinine because the time lapse between adding creatine to water and ingesting it is short.

しかし、前述の通り、クレアチンは水に難溶性であることから、水に加えてもほぼ全量が沈殿し、ざらつきや溶け残りによる不快感を受けやすい。さらに、生体内への吸収効率が悪いことが予想される。そのため、クレアチン摂取の利便性やクレアチン吸収効率の改善の観点から、水分散性が良好なクレアチン含有組成物の開発が期待されている。   However, as described above, since creatine is poorly soluble in water, almost all the amount of creatine precipitates even when added to water, and the creatine is susceptible to discomfort due to roughness and undissolved residue. Furthermore, it is expected that the absorption efficiency into the living body will be poor. Therefore, from the viewpoint of convenience of creatine intake and improvement of creatine absorption efficiency, development of a creatine-containing composition having good water dispersibility is expected.

こうした状況を受け、クレアチンを摂取しやすくするために、クレアチンに関して種々の製剤が提案されている。例えば、特許文献1においては、クレアチンは溶解性が低いため、砂的なザラザラした食感を有し、また、クレアチンを微粉砕化して顆粒又は錠剤にすると、噛んだ際に歯に詰まる現象が生じることから、粒子径 5μm〜200μmのクレアチンを含有させることにより、高用量でもざらつきがなく、歯付きの少ない、顆粒及び圧縮成型した錠剤形態の食品又は医薬品を製造する方法が報告されている。   Under these circumstances, various preparations have been proposed for creatine in order to make it easier to take creatine. For example, in Patent Document 1, since creatine has a low solubility, it has a gritty texture, and when creatine is finely pulverized into granules or tablets, there is a phenomenon that teeth are clogged when chewed. Therefore, a method for producing a food or pharmaceutical product in the form of granules and compression tablets, which is free from roughness even at a high dose and has few teeth, has been reported by containing creatine having a particle size of 5 μm to 200 μm.

また、特許文献2においては、生体への吸収性にすぐれ、かつ、水溶解性の大きいクレアチンを提供するため、クレアチンを非水系溶媒に分散させた後、ビーズサイズ1mm以下のビーズミルにかけて粉砕して得た、平均粒子径2μm以下の微粉化クレアチンが報告されている。   Further, in Patent Document 2, in order to provide creatine having excellent absorbability to living bodies and having high water solubility, creatine is dispersed in a non-aqueous solvent and then crushed by applying a bead mill having a bead size of 1 mm or less. The obtained finely divided creatine having an average particle diameter of 2 μm or less is reported.

特許第3892610号公報Japanese Patent No. 3892610 特開2007−39408号公報JP-A-2007-39408

しかしながら、特許文献1に示されたクレアチンの製剤においては、その剤形が顆粒及び錠剤であり、水溶解性や分散性、生体への吸収性については言及されていない。   However, in the preparation of creatine shown in Patent Document 1, the dosage form is granules and tablets, and there is no mention of water solubility, dispersibility and absorbability into living bodies.

また、特許文献2に示されたクレアチンの微粉末においては、その溶解度は21g/L(10℃水)であり、クレアチンの前記効果が得られると考えられているクレアチンの前記必要量を、前記微粉末を溶解させた飲料で摂取するには、多量の飲料摂取が必要である。また、前記微粉末の製造においては、多量のエタノール等の溶媒を使用する点から、実製造を考えると現実的でない。   Further, in the creatine fine powder disclosed in Patent Document 2, the solubility thereof is 21 g / L (10 ° C. water), and the necessary amount of creatine which is considered to obtain the above-mentioned effect of creatine is Ingestion with a beverage in which fine powder is dissolved requires ingestion of a large amount of beverage. In addition, in the production of the fine powder, a large amount of a solvent such as ethanol is used, so that it is not realistic from the viewpoint of actual production.

このように、クレアチン製剤に関する従来技術では、クレアチンの水分散性が十分ではなく、特に粉末飲料として使用する際の利便性という点では、十分に満足できるものではなかった。クレアチン製剤の剤形に関して言えば、水等を加えた上で飲用する粉末飲料の形態は、特にスポーツシーンで、筋肉の増強や筋肉分解の抑制のためにクレアチンを効率良く素早く補充する剤形として特に有用であるため、粉末飲料の剤形でのクレアチン製剤の提供が期待されている。   As described above, the conventional techniques relating to creatine preparations are not sufficient in water dispersibility of creatine, and are not particularly satisfactory in terms of convenience when used as a powdered beverage. Regarding the dosage form of creatine preparations, the form of powdered drink to be dripped after adding water etc. is as a dosage form that efficiently and quickly supplements creatine for muscle strengthening and suppression of muscle decomposition, especially in sports scenes. Since it is particularly useful, it is expected to provide a creatine formulation in the form of a powdered beverage.

そこで、本発明は、クレアチンの水分散性が良好であり、また従来技術では提供することが困難であった剤形、すなわち、飲料及び粉末飲料の形態で提供することができるため、サプリメントとして利用する際の利便性が高い、クレアチン含有水分散性粉末状組成物及びその製造方法を提供することを目的とする。   Therefore, the present invention has good water dispersibility of creatine, and since it can be provided in a dosage form which was difficult to provide by the conventional technique, that is, a beverage and a powdered beverage, it is used as a supplement. It is an object of the present invention to provide a creatine-containing water-dispersible powdery composition and a method for producing the same, which is highly convenient for use.

本発明者は、上記課題を解決するため鋭意研究した結果、クレアチンを乳化剤と共に高温の水に溶解させた後、噴霧乾燥することによって、水分散性が高められた粉末を得ることを見出し、本発明を完成するに至った。   The present inventor, as a result of intensive research to solve the above problems, after dissolving creatine in hot water together with an emulsifier, by spray drying, it was found that to obtain a powder with enhanced water dispersibility, the present The invention was completed.

本発明は、以下の[1]〜[6]に関するものである。
[1] クレアチン100質量部に対し、乳化剤0.1〜10重量部を含み、クレアチンの表面の一部又は全部を前記乳化剤で被覆してなることを特徴とするクレアチン含有水分散性粉末状組成物。
[2] 前記乳化剤が、グリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、及びレシチン類からなる群より選択される1又は2以上である前記[1]に記載の水分散性粉末状組成物。
[3] 前記水分散性粉末状組成物の平均粒子径が40μm以下である前記[1]又は[2]に記載の水分散性粉末状組成物。
[4] 前記[1]〜[3]のいずれかに記載の水分散性粉末状組成物を含むことを特徴とする飲食品、医薬品又は医薬部外品。
[5] 剤形が飲料又は粉末飲料である前記[4]に記載の飲食品、医薬品又は医薬部外品。
[6] クレアチン100質量部に対し、乳化剤0.1〜10質量部、及び水500〜2000質量部を加えて混合し、80〜100℃の範囲に加熱して溶解させ、水溶液を調製する第1工程と、
前記水溶液を噴霧乾燥することによって微粉末を得る第2工程とを含むことを特徴とするクレアチン含有水分散性粉末状組成物の製造方法。
The present invention relates to the following [1] to [6].
[1] Creatine-containing water-dispersible powdery composition, characterized by containing 0.1 to 10 parts by weight of an emulsifier with respect to 100 parts by mass of creatine, and coating a part or all of the surface of creatine with the emulsifier. Stuff.
[2] The water-dispersible powdery composition according to the above [1], wherein the emulsifier is one or more selected from the group consisting of glycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, and lecithins. .
[3] The water-dispersible powdery composition according to the above [1] or [2], wherein the water-dispersible powdery composition has an average particle diameter of 40 μm or less.
[4] A food or drink, a drug or a quasi drug, comprising the water-dispersible powdery composition according to any one of [1] to [3].
[5] The food and drink, the drug or the quasi drug according to the above [4], wherein the dosage form is a drink or a powdered drink.
[6] To 100 parts by mass of creatine, 0.1 to 10 parts by mass of an emulsifier and 500 to 2000 parts by mass of water are added and mixed, and heated in a range of 80 to 100 ° C. to be dissolved to prepare an aqueous solution. 1 step,
A second step of obtaining a fine powder by spray drying the aqueous solution, the method for producing a creatine-containing water-dispersible powdery composition.

本発明は、クレアチンの水分散性が十分に改善されているため、水や水系溶媒、飲料に分散させるとクレアチン粒子が安定して分散し、沈殿や凝集等を生じることが少なく、そのため、クレアチンが摂取しやすくなり、生体内への吸収性が向上する。また、クレアチンを効率良く素早く補充できる剤形である飲料及び粉末飲料の形態で提供できるため、サプリメントとして利用する際の利便性を大きく高めることができる。   The present invention, because the water dispersibility of creatine is sufficiently improved, water or water-based solvent, creatine particles are stably dispersed when dispersed in a beverage, precipitation or aggregation is less likely to occur, therefore, creatine. Is easily ingested, and absorbability into the body is improved. In addition, since it can be provided in the form of a drink or a powdered drink that is a dosage form capable of efficiently and quickly supplementing creatine, the convenience of using it as a supplement can be greatly enhanced.

実施例1〜9、比較例1、2で得られた粉末を水に加え十分に振とうして分散させてから1分後の状態(上段左から実施例1〜5、下段左から実施例6〜9、比較例1、2)を示す説明図である。One minute after the powders obtained in Examples 1 to 9 and Comparative Examples 1 and 2 were added to water and sufficiently shaken to disperse (Examples 1 to 5 from the upper left, Examples from the lower left 6 to 9 and Comparative Examples 1 and 2) are explanatory views. 実施例1〜9で得られた微粉末について、水に分散させてからの時間経過による沈殿量の変化を示す図である。It is a figure which shows the change of the precipitation amount with time progress after disperse | distributing in the fine powder obtained in Examples 1-9 in water. 実施例1〜9で得られた微粉末を水に分散させてから120分経過時の状態(上段左から実施例1〜5、下段左から実施例6〜9)を示す説明図である。It is explanatory drawing which shows the state after 120 minutes passed after disperse | distributing the fine powder obtained in Examples 1-9 in water (Examples 1-5 from an upper stage left, Examples 6-9 from a lower stage left).

以下、本発明について詳細に説明する。まず、本発明の組成物について説明する。本発明の組成物は、前述したとおり、クレアチン100質量部に対し、乳化剤0.1〜10重量部を含み、クレアチンの表面の一部又は全部を前記乳化剤で被覆してなることを特徴とするクレアチン含有水分散性粉末状組成物である。   Hereinafter, the present invention will be described in detail. First, the composition of the present invention will be described. As described above, the composition of the present invention is characterized by containing 0.1 to 10 parts by weight of an emulsifier with respect to 100 parts by weight of creatine, and coating a part or all of the surface of creatine with the emulsifier. It is a water-dispersible powdery composition containing creatine.

本発明において、クレアチン(1−メチルグアニジノ酢酸)とは、厳密にはクレアチン一水和物を指すが、無水物、クレアチンリン酸塩等のクレアチン塩が含まれる。一般的に市販されているものを使用して差し支えなく、その種類や性状は特に限定されない。また、クレアチン又はクレアチン塩を単品で用いてもよいし、クレアチン及びクレアチン塩を組み合わせて用いてもよい。種々の方法で得られる2種以上のクレアチン及び/又はその塩の組み合わせであってもよいし、クレアチンの2種以上の塩を組み合わせたものであってもよい。生体内において、クレアチンは、アルギニン、グリシン、メチオニンから合成される物質であり、通常の食生活において不足することはない。しかし、高強度の運動を行うアスリートや、病気や怪我によって十分な栄養が取れない状態でリハビリを行う患者などでは、クレアチンが不足する傾向がみられる。   In the present invention, creatine (1-methylguanidinoacetic acid) strictly refers to creatine monohydrate, but includes creatine salts such as anhydrides and creatine phosphate. Generally commercially available products may be used, and the types and properties thereof are not particularly limited. In addition, creatine or creatine salt may be used alone, or creatine and creatine salt may be used in combination. It may be a combination of two or more kinds of creatine and / or a salt thereof obtained by various methods, or may be a combination of two or more kinds of creatine salts. In the living body, creatine is a substance synthesized from arginine, glycine and methionine, and there is no deficiency in normal diet. However, creatine tends to be deficient in athletes who perform high-intensity exercise and patients who rehabilitate due to insufficient nutrition due to illness or injury.

本発明の組成物の特徴の1つは、クレアチン100質量部に対して、乳化剤を0.1〜10質量部含むことである。乳化剤を加えることで、クレアチンの水分散性をより高めることができる。10質量部より多いと、経時で沈殿したクレアチンが固結し、再分散させることが困難になり、また、噴霧乾燥による製造の場合は、噴霧乾燥機への送液中に配管内でクレアチンが再結晶化・固結する傾向が強くなるため実製造する上で支障が生じる恐れがある。また、0.1質量部未満では少なすぎて良好な水分散性が得られない。乳化剤の割合が増えていくと、水への分散時に沈殿相が再分散しにくくなるが、沈殿を生じる速度が低下し、熱が加わった際の溶解及び再結晶化が抑制される傾向がみられる。このことから、最終的な用途に合わせて上記範囲内で配合率を決定するとよい。また、これを考慮すると、乳化剤量は0.1〜9質量部であることが望ましい。さらに、クレアチン100質量部に対して、乳化剤量が3〜9質量部、より好ましくは5〜9質量部であると水分散性に加えて、水分散安定性も向上するためより望ましい。なお、水分散性とは、粒子が水に浮遊・懸濁する程度、水分散安定性とは、水中において分散状態が時間の経過とともに変化しない程度を表す。   One of the characteristics of the composition of the present invention is that it contains 0.1 to 10 parts by mass of an emulsifier with respect to 100 parts by mass of creatine. By adding an emulsifier, the water dispersibility of creatine can be further enhanced. If it is more than 10 parts by mass, the creatine that has precipitated over time will solidify, making it difficult to re-disperse it. Further, in the case of production by spray drying, creatine will be generated in the pipe during liquid transfer to the spray dryer. Since the tendency to recrystallize and solidify becomes stronger, there may be a problem in actual production. On the other hand, if the amount is less than 0.1 part by mass, the amount is too small to obtain good water dispersibility. When the proportion of emulsifier increases, it becomes difficult for the precipitation phase to re-disperse when dispersed in water, but the rate of precipitation is reduced, and dissolution and recrystallization when heat is applied tend to be suppressed. To be From this, it is advisable to determine the blending ratio within the above range according to the final application. Further, in consideration of this, the amount of the emulsifier is preferably 0.1 to 9 parts by mass. Furthermore, it is more desirable that the amount of the emulsifier is 3 to 9 parts by mass, more preferably 5 to 9 parts by mass, relative to 100 parts by mass of creatine, in addition to the water dispersibility, the water dispersion stability is improved. The water dispersibility means the degree to which particles are suspended or suspended in water, and the water dispersion stability means the degree to which the dispersed state does not change with time in water.

前記乳化剤の種類は、本発明の効果を妨げない限り制限されない。また単独で使用してもよく、2種以上併用してもよい。前記乳化剤として、グリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、レシチン類、アラビアガム、加工デンプン等が挙げられる。これらの中でも、特にショ糖脂肪酸エステルが好ましく使用される。   The type of the emulsifier is not limited as long as it does not impair the effects of the present invention. They may be used alone or in combination of two or more. Examples of the emulsifier include glycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, lecithins, gum arabic, modified starch and the like. Among these, sucrose fatty acid ester is particularly preferably used.

また、クレアチン、前記乳化剤とは別に賦形剤を用いてもよい。例えば、乳化作用をもたないデキストリン、マルトデキストリン、デンプン、乳糖なども使用できる。   Further, an excipient may be used separately from creatine and the emulsifier. For example, dextrin, maltodextrin, starch and lactose which do not have an emulsifying action can be used.

本発明の組成物は、クレアチンを核として、その表面の一部又は全部を前記乳化剤で被覆してなるものである。クレアチンに前記乳化剤を被覆するには、本発明の効果が得られる限りにおいてどのような方法を使用してもよいが、後述するように、クレアチニン及び前記乳化剤を完全に溶解させた水溶液を噴霧乾燥して被覆する方法が、簡便かつ確実に目的物が得られるという点で好ましい。   The composition of the present invention has creatine as a core, and a part or all of the surface thereof is coated with the emulsifier. In order to coat creatine with the emulsifier, any method may be used as long as the effects of the present invention can be obtained, but as described below, creatinine and the aqueous solution in which the emulsifier is completely dissolved are spray-dried. The coating method is preferable in that the target product can be obtained easily and surely.

本発明の組成物の平均粒子径は、40μm以下であることが望ましく、20μm以下であることがより望ましい。微細化した粒子は小さければ小さいほど、水分散性が増すが、40μmよりも大きいと水分散性が良好であるとはいえなくなる。なお、前記平均粒子径は、前記組成物をエタノールに分散させて、レーザー回折散乱法を利用して測定することができる。   The average particle diameter of the composition of the present invention is preferably 40 μm or less, and more preferably 20 μm or less. The smaller the finer particles, the more the water dispersibility increases, but if it is larger than 40 μm, the water dispersibility cannot be said to be good. The average particle size can be measured by dispersing the composition in ethanol and using a laser diffraction / scattering method.

本発明の組成物はそのままの形態で最終製品として用いてもよいし、クレアチンを有効成分として上記以外の成分を有していても構わない。すなわち、本組成物は飲食品用、医薬用、医薬部外品用の添加剤として用いることができる。   The composition of the present invention may be used as it is as a final product, or may have a component other than the above as an active ingredient of creatine. That is, the present composition can be used as an additive for food and drink, medicine, and quasi drugs.

その際に使用される基剤や他の添加剤は、本発明の目的を損なわない限り特に限定されることはなく、最終製品の剤形や用途に応じて選択すればよい。   The base and other additives used in that case are not particularly limited as long as the object of the present invention is not impaired, and may be selected according to the dosage form and end use of the final product.

本発明の組成物は、そのまま組成物粉末として摂取することもできるが、水等の水系溶媒に加えた上で飲用する粉末飲料又は飲料の剤形への利用に供することもできる。本発明の組成物を粉末飲料として利用する場合、本発明の組成物を水等の水系溶媒に加えると素早く均一に分散するため摂取が容易であり、また、経時変化なく長期間保管することができる。また、本発明の組成物を飲料として利用する場合は、水系溶媒に本発明の組成物を分散させた後の加熱時において該組成物は再結晶しにくい、すなわち、殺菌工程を経ても沈殿が生じにくいという特徴がある。これらの剤形は、特にスポーツシーンで、運動パフォーマンスの増加や筋肉の増強のためにクレアチンを効率良く素早く補充する剤形として特に有用である。その他、所望の形状等に成型し、各種の剤形にて提供することができる。   The composition of the present invention can be ingested as a composition powder as it is, but can also be used in the form of a powdered beverage or a beverage to be dripped after being added to an aqueous solvent such as water. When the composition of the present invention is used as a powdered beverage, it is easy to ingest because the composition of the present invention is quickly and uniformly dispersed when added to an aqueous solvent such as water, and can be stored for a long time without change over time. it can. Further, when the composition of the present invention is used as a beverage, the composition is difficult to recrystallize during heating after dispersing the composition of the present invention in an aqueous solvent, that is, a precipitate is formed even after a sterilization step. It has a characteristic that it hardly occurs. These dosage forms are particularly useful as a dosage form for efficiently and quickly supplementing with creatine in order to increase exercise performance and strengthen muscles, especially in sports scenes. In addition, it can be molded into a desired shape and the like and provided in various dosage forms.

本発明の組成物は粒子の微細化により、生体内への吸収性が高められている。そのため、従来必要とされてきた摂取量未満の摂取においても、従来と同等の効果を発揮する可能性がある。   The composition of the present invention has improved absorbability into the living body due to finer particles. Therefore, even if the intake is less than the conventionally required intake, there is a possibility of exhibiting the same effect as the conventional one.

本発明の組成物では、特に水分散性の改善が顕著にみられる。よって、例えば、粉末飲料への配合によって、水に容易に分散し、経時で均一な分散状態を維持し、不快感を生じることなく飲用でき、吸収性の高められた商品を提案することができる。   In the composition of the present invention, the water dispersibility is remarkably improved. Therefore, for example, by blending with a powdered beverage, it can be easily dispersed in water, maintain a uniform dispersed state over time, can be drunk without causing discomfort, and a product with enhanced absorbability can be proposed. .

次に、本発明の製造方法について述べる。前述した本発明の組成物は、本発明の効果が得られる限りにおいてどのような方法を使用して製造してもよいが、本発明の製造方法、すなわち、クレアチン100質量部に対し、乳化剤0.1〜10質量部、及び水500〜2000質量部を加えて混合し、80〜100℃の範囲に加熱して溶解させ、水溶液を調製する第1工程と、前記水溶液を噴霧乾燥することによって、平均粒子径が40μm以下である微粉末を得る第2工程とを含む製造方法により製造することが、他の製造方法(例えば、粉砕処理)に比べて、平均粒子径が小さくて、水分散性及び水分散安定性が高い目的物を簡便かつ確実に得られるという点で好ましい。   Next, the manufacturing method of the present invention will be described. The composition of the present invention described above may be produced by any method as long as the effects of the present invention can be obtained. However, the production method of the present invention, that is, 100 parts by mass of creatine, 0 emulsifier is used. 1 to 10 parts by mass and 500 to 2000 parts by mass of water are added and mixed, and the mixture is heated to a temperature in the range of 80 to 100 ° C. to be dissolved to prepare an aqueous solution, and by spray drying the aqueous solution. And a second step of obtaining a fine powder having an average particle size of 40 μm or less, the average particle size is smaller than that of other manufacturing methods (for example, pulverization), Is preferred in that the target product having high properties and high water dispersion stability can be simply and reliably obtained.

第1工程においては、クレアチン及び前記乳化剤の所定量に対し、水500〜2000質量部、好ましくは600〜1000質量部を加えて混合する。500質量部未満では、クレアチンを十分に溶かすことが困難となり、また、後述する噴霧乾燥機への送液中にクレアチンが再結晶化してしまう恐れがあり、一方、2000質量部を超えると、クレアチンを前記乳化剤で十分に被覆させることが困難となる。   In the first step, 500 to 2000 parts by mass, preferably 600 to 1000 parts by mass of water is added and mixed with a predetermined amount of creatine and the emulsifier. If it is less than 500 parts by mass, it will be difficult to sufficiently dissolve creatine, and there is a risk that creatine will be recrystallized during sending to a spray dryer described later, while if it exceeds 2000 parts by mass, creatine will be It becomes difficult to sufficiently coat the above with the emulsifier.

また、第1工程においては、クレアチン、前記乳化剤、及び水を混合する際、80〜100℃、好ましくは85〜95℃の範囲に加熱して、クレアチンを溶かして水溶液を調製する。この水溶液は第2工程で噴霧乾燥する対象である噴霧液となる。この噴霧液は、クレアチン及び前記乳化剤が完全に溶解されている必要があるため、前述したように、80〜100℃でクレアチン、前記乳化剤、及び水を混合する。この場合、80℃未満ではクレアチンを十分に溶かすことが困難となり、一方、100℃を超えると、クレアチンは熱に弱いため、熱によりクレアチンが破壊される恐れがある。なお、クレアチン、乳化剤については前述の通りである。また、前記温度範囲において加熱する時間は、60分以下、好ましくは30分以下である。60分よりも加熱する時間が長くなると、クレアチンの活性が低下する恐れがある。   In addition, in the first step, when creatine, the emulsifier, and water are mixed, the mixture is heated to a temperature in the range of 80 to 100 ° C, preferably 85 to 95 ° C to dissolve the creatine to prepare an aqueous solution. This aqueous solution becomes the spray liquid that is the target of spray drying in the second step. Since this spray solution needs to completely dissolve creatine and the emulsifier, as described above, creatine, the emulsifier, and water are mixed at 80 to 100 ° C. In this case, if the temperature is lower than 80 ° C., it becomes difficult to sufficiently dissolve creatine, while if the temperature exceeds 100 ° C., creatine may be destroyed by heat because it is weak against heat. The creatine and emulsifier are as described above. The heating time in the above temperature range is 60 minutes or less, preferably 30 minutes or less. If the heating time is longer than 60 minutes, the activity of creatine may decrease.

第2工程においては、第1工程で調製した水溶液(噴霧液)を噴霧乾燥することによって微粉末、すなわち、本発明の組成物を得る。この組成物は、クレアチンを核としてその表面に前記乳化剤が固着したものである。噴霧乾燥は粉末化したい物質を溶媒に溶かし、それを高温下で噴霧することで溶媒を除去して瞬間的に乾燥させ、粉末を得る手法である。本発明において噴霧乾燥を行う装置は、一般に知られている噴霧乾燥機を使用すればよい。特別な付加設備も必要なく、装置側の噴霧時の条件は、各々の装置に応じて調整して差し支えない。   In the second step, the aqueous solution (spray solution) prepared in the first step is spray-dried to obtain a fine powder, that is, the composition of the present invention. This composition has creatine as a core and the emulsifier fixed to the surface thereof. Spray drying is a method of dissolving a substance to be powdered in a solvent, spraying it at a high temperature to remove the solvent, and instantaneously drying it to obtain a powder. A generally known spray dryer may be used as a device for performing spray drying in the present invention. No special additional equipment is required, and conditions for spraying on the device side may be adjusted according to each device.

前記水溶液は、その調製後、速やかに噴霧乾燥処理を行うことが望ましい。また噴霧処理時も保温し、可能な限り液温が低下しないようにする。具体的には、液温を80〜100℃、好ましくは85〜95℃に維持しながら噴霧乾燥処理を行うのが好ましい。液温が80℃未満に低下すると、噴霧乾燥機への送液中にクレアチンが再結晶化してしまう恐れがあり、一方、100℃を超えると、熱によりクレアチンが破壊される恐れがある。   It is desirable that the aqueous solution be spray-dried immediately after its preparation. Also, keep the temperature warm during the spraying process so that the liquid temperature does not drop as much as possible. Specifically, it is preferable to carry out the spray drying treatment while maintaining the liquid temperature at 80 to 100 ° C, preferably 85 to 95 ° C. When the liquid temperature is lower than 80 ° C., creatine may be recrystallized during the feeding to the spray dryer, while when it is higher than 100 ° C., heat may destroy the creatine.

本発明の製造方法は、前述した噴霧乾燥処理を行うことを特徴としている。噴霧乾燥処理ではなく、ピンミルやハンマーミル等の粉砕機を用いる方法では、本発明の性能上必要な平均粒子径以下までクレアチン結晶を微細化できず、また、クレアチンを核としてその表面に乳化剤を適切に付着させることができないため、本発明の効果である水分散性が十分に得られない場合がありうる。もしくは微細化に時間が掛かり、実製造に向かない。   The manufacturing method of the present invention is characterized by performing the above-mentioned spray drying treatment. In the method of using a pulverizer such as a pin mill or a hammer mill, instead of spray drying treatment, it is not possible to refine the creatine crystals to an average particle size or less required for the performance of the present invention, and an emulsifier on the surface of the creatine as a core. Since the particles cannot be properly attached, the water dispersibility which is the effect of the present invention may not be sufficiently obtained. Alternatively, it takes time to miniaturize and is not suitable for actual manufacturing.

微細化した粒子は小さければ小さいほど、水分散性が増すが、十分な水分散性を得るためには、噴霧乾燥で得られた微粉末の平均粒子径は、40μm以下であることが望ましく、20μm以下であることがより望ましい。   The smaller the finer particles, the more the water dispersibility increases, but in order to obtain sufficient water dispersibility, the average particle size of the fine powder obtained by spray drying is preferably 40 μm or less, More preferably, it is 20 μm or less.

本発明の製造方法は、前記第1工程、第2工程に加えて、必要に応じてさらに他の工程を含んでもよい。例えば、前記水溶液に食品原料及び/又は食品添加物を加えて混合させる工程を追加することができる。   The manufacturing method of the present invention may further include other steps, if necessary, in addition to the first step and the second step. For example, a step of adding a food material and / or a food additive to the aqueous solution and mixing them can be added.

以下、実施例により本発明をさらに具体的に説明する。なお、本発明はこれらに限定されるものではない。   Hereinafter, the present invention will be described in more detail with reference to Examples. The present invention is not limited to these.

[実施例1〜9、比較例1、2]
1.微細化方法による水分散性の違い
クレアチン(フィトファーマ株式会社製)と、乳化剤としてショ糖脂肪酸エステル(三菱ケミカルフーズ株式会社製)を表1に記載の割合で配合し、水700質量部に加え、密封状態・90℃で30分間加熱して完全に溶解させた。その後速やかに噴霧乾燥処理し、微粉末(実施例1〜5)を得た。また、クレアチン(フィトファーマ株式会社製)と前記乳化剤(三菱ケミカルフーズ株式会社製)を表1に記載の割合で配合し、自由粉砕機で粉砕処理して粉末(実施例6〜9)を得た。
一方、比較対象として、粉砕処理を行っていない無処理のクレアチン(フィトファーマ株式会社製)を比較例1とした。また、クレアチン(フィトファーマ株式会社製)と前記乳化剤(三菱ケミカルフーズ株式会社製)を表1に記載の割合で配合し、よく混合して粉末(比較例2)を得た。
実施例1〜9と比較例1、2において得られた粉末をエタノールに分散させ、レーザー回折散乱法にて平均粒子径を測定した(表1を参照)。
実施例1〜9と比較例1、2で得られた粉末の水分散性を比較するため、実施例1〜9と比較例1、2で得られた各粉末5gを水50gに加え、十分に振とうして分散させてから1分後の状態を目視で観察し、図1に示した(上段左から実施例1〜5、下段左から実施例6〜9、比較例1、2)。
[Examples 1 to 9 and Comparative Examples 1 and 2]
1. Difference in water dispersibility depending on the micronization method Creatine (manufactured by Phyto Pharma Co., Ltd.) and sucrose fatty acid ester (manufactured by Mitsubishi Chemical Foods Co., Ltd.) as an emulsifier were blended at a ratio shown in Table 1, and added to 700 parts by mass of water. , Sealed state, heated at 90 ° C. for 30 minutes to completely dissolve. After that, spray-drying treatment was promptly performed to obtain fine powders (Examples 1 to 5). In addition, creatine (manufactured by Phyto Pharma Co., Ltd.) and the emulsifier (manufactured by Mitsubishi Chemical Foods Co., Ltd.) were blended in a ratio shown in Table 1, and pulverized by a free pulverizer to obtain powders (Examples 6 to 9). It was
On the other hand, as a comparative object, untreated creatine (manufactured by Phyto Pharma Co., Ltd.) which has not been crushed is used as Comparative Example 1. Further, creatine (manufactured by Phyto Pharma Co., Ltd.) and the emulsifier (manufactured by Mitsubishi Chemical Foods Co., Ltd.) were blended in a ratio shown in Table 1 and mixed well to obtain a powder (Comparative Example 2).
The powders obtained in Examples 1 to 9 and Comparative Examples 1 and 2 were dispersed in ethanol, and the average particle size was measured by the laser diffraction scattering method (see Table 1).
In order to compare the water dispersibility of the powders obtained in Examples 1 to 9 and Comparative Examples 1 and 2, 5 g of each powder obtained in Examples 1 to 9 and Comparative Examples 1 and 2 was added to 50 g of water, and After 1 minute of shaking and dispersion, the state was visually observed and shown in FIG. 1 (Examples 1 to 5 from the upper left, Examples 6 to 9 from the lower left, Comparative Examples 1 and 2). .

Figure 2020058297
Figure 2020058297

(結果)
図1からわかるように、実施例1〜9では、均一で良好な水分散性が観察されたのに対し、比較例1、2では、短時間で沈殿が認められ、均一で良好な水分散性は観察されなかった。また、噴霧乾燥処理を行った実施例1〜5は、自由粉砕機で粉砕処理を行った実施例6〜9に比べて平均粒子径が小さく、より高い水分散性の向上を実現できることが示された。実施例4と実施例7、8では平均粒子径のサイズに大きな差はないが、水分散性は異なっていた。すなわち、単純に粒子径を小さくするだけではなく、噴霧乾燥処理を行うことで、より高い水分散性の向上を実現できることが立証された。
(result)
As can be seen from FIG. 1, in Examples 1 to 9, uniform and good water dispersibility was observed, whereas in Comparative Examples 1 and 2, precipitation was observed in a short time, and uniform and good water dispersion was observed. No sex was observed. In addition, Examples 1 to 5 subjected to the spray drying treatment have a smaller average particle diameter than Examples 6 to 9 subjected to the pulverization treatment with a free pulverizer, and it is possible to realize higher improvement in water dispersibility. Was done. Example 4 and Examples 7 and 8 were different from each other in water dispersibility, although there was no big difference in the average particle size. That is, it was proved that not only simply reducing the particle diameter but also performing spray drying treatment can realize higher improvement in water dispersibility.

2.水分散安定性の違い
さらに、実施例1〜9で得られた微粉末について、水分散安定性を評価するため、水に分散させてからの時間経過による沈殿量の変化を図2に示した。「クレアチン分散相の高さ/液面の高さ」の値を百分率で表し、これを図2の縦軸に示し、経過時間を横軸に示した。上記の値が小さいほど沈殿が進んでおり、分散安定性が低いことを表す。なお、実施例1〜9で得られた微粉末を水に分散させてから120分経過時の状態を示す写真(上段左から実施例1〜5、下段左から実施例6〜9)を図3に示した。
2. Difference in Water Dispersion Stability Furthermore, in order to evaluate the water dispersion stability of the fine powders obtained in Examples 1 to 9, changes in the amount of precipitation with the passage of time after being dispersed in water are shown in FIG. . The value of “height of creatine dispersed phase / height of liquid surface” is expressed in percentage, which is shown on the vertical axis of FIG. 2 and the elapsed time is shown on the horizontal axis. The smaller the above value is, the more the precipitation is advanced and the dispersion stability is low. In addition, the photographs showing the state after 120 minutes have passed since the fine powders obtained in Examples 1 to 9 were dispersed in water (Examples 1 to 5 from the upper left, Examples 6 to 9 from the lower left) are illustrated. Shown in 3.

(結果)
図2に示した結果からわかるように、特に実施例1〜5で得られた微粉末は120分経過後においても前記値が47〜100%の範囲を示し、高い水分散安定性を呈することが確認された。他方、粉砕処理で調製した実施例6〜9は、噴霧乾燥処理で調製した実施例1〜5よりも低い水分散安定性であった。また、実施例1〜5の中で見ると、実施例5は最も高い水分散安定性、次に実施例4が高い水分散安定性を呈し、実施例1は最も低い水分散安定性を呈した。実施例4、5で得られた微粉末は実施例2で得られたものより平均粒子径が大きく、実施例3で得られた微粉末は実施例2で得られたものと平均粒子径が同じであることから、単純に粒子径を小さくするだけではなく、乳化剤の配合量が水分散安定性に大きく影響することがわかった。
(result)
As can be seen from the results shown in FIG. 2, the fine powders obtained in Examples 1 to 5 show the above range of 47 to 100% even after 120 minutes, and exhibit high water dispersion stability. Was confirmed. On the other hand, Examples 6 to 9 prepared by the pulverization treatment had lower aqueous dispersion stability than Examples 1 to 5 prepared by the spray drying treatment. In addition, among Examples 1 to 5, Example 5 exhibits the highest water dispersion stability, then Example 4 exhibits the highest water dispersion stability, and Example 1 exhibits the lowest water dispersion stability. did. The fine powders obtained in Examples 4 and 5 have larger average particle diameters than those obtained in Example 2, and the fine powders obtained in Example 3 have the same average particle diameters as those obtained in Example 2. From the fact that they are the same, it was found that not only the particle size was simply reduced, but also the compounding amount of the emulsifier had a great influence on the water dispersion stability.

Claims (6)

クレアチン100質量部に対し、乳化剤0.1〜10重量部を含み、クレアチンの表面の一部又は全部を前記乳化剤で被覆してなることを特徴とするクレアチン含有水分散性粉末状組成物。   A creatine-containing water-dispersible powdery composition, which comprises 0.1 to 10 parts by weight of an emulsifier with respect to 100 parts by mass of creatine, and is obtained by coating a part or all of the surface of creatine with the emulsifier. 前記乳化剤が、グリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、及びレシチン類からなる群より選択される1又は2以上である請求項1に記載の水分散性粉末状組成物。   The water-dispersible powdery composition according to claim 1, wherein the emulsifier is one or more selected from the group consisting of glycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid ester, and lecithin. 前記水分散性粉末状組成物の平均粒子径が40μm以下である請求項1又は2に記載の水分散性粉末状組成物。   The water-dispersible powdery composition according to claim 1, wherein the water-dispersible powdery composition has an average particle diameter of 40 μm or less. 請求項1〜3のいずれか1項に記載の水分散性粉末状組成物を含むことを特徴とする飲食品、医薬品又は医薬部外品。   A food or drink, a pharmaceutical product, or a quasi drug, comprising the water-dispersible powdery composition according to any one of claims 1 to 3. 剤形が飲料又は粉末飲料である請求項4に記載の飲食品、医薬品又は医薬部外品。   The food or drink, the drug or the quasi drug according to claim 4, wherein the dosage form is a drink or a powdered drink. クレアチン100質量部に対し、乳化剤0.1〜10質量部、及び水500〜2000質量部を加えて混合し、80〜100℃の範囲に加熱して溶解させ、水溶液を調製する第1工程と、
前記水溶液を噴霧乾燥することによって微粉末を得る第2工程とを含むことを特徴とするクレアチン含有水分散性粉末状組成物の製造方法。

With respect to 100 parts by mass of creatine, 0.1 to 10 parts by mass of an emulsifier and 500 to 2000 parts by mass of water are added and mixed, and heated in a range of 80 to 100 ° C. to be dissolved to prepare an aqueous solution. ,
A second step of obtaining a fine powder by spray drying the aqueous solution, the method for producing a creatine-containing water-dispersible powdery composition.

JP2018192372A 2018-10-11 2018-10-11 Creatine-containing water-dispersible powdery composition and its production method Active JP7089278B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018192372A JP7089278B2 (en) 2018-10-11 2018-10-11 Creatine-containing water-dispersible powdery composition and its production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018192372A JP7089278B2 (en) 2018-10-11 2018-10-11 Creatine-containing water-dispersible powdery composition and its production method

Publications (2)

Publication Number Publication Date
JP2020058297A true JP2020058297A (en) 2020-04-16
JP7089278B2 JP7089278B2 (en) 2022-06-22

Family

ID=70218571

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018192372A Active JP7089278B2 (en) 2018-10-11 2018-10-11 Creatine-containing water-dispersible powdery composition and its production method

Country Status (1)

Country Link
JP (1) JP7089278B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023242126A1 (en) * 2022-06-14 2023-12-21 Alzchem Trostberg Gmbh Water-soluble creatine agglomerate

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151593A1 (en) * 2001-04-13 2002-10-17 James Stitley Water-soluble creatine monohydrate formulations and process for their preparation
JP2003300885A (en) * 2003-06-24 2003-10-21 Meiji Seika Kaisha Ltd Antibacterial pharmaceutical composition
JP2003325114A (en) * 2002-05-14 2003-11-18 Dai Ichi Kogyo Seiyaku Co Ltd Coating agent for oral ingestion product
JP2007039408A (en) * 2005-08-05 2007-02-15 Unitec Foods Co Ltd Pulverized creatine and method for producing the same
JP2007131609A (en) * 2005-11-11 2007-05-31 Bhn Kk Composition for reinforcing endurance, preventing or recovering fatigue, or strengthening nourishment
JP2008184385A (en) * 2007-01-26 2008-08-14 Ezaki Glico Co Ltd Dispersed hesperetin
WO2019079651A1 (en) * 2017-10-18 2019-04-25 Glanbia Nutritionals (Ireland) Ltd. Shelf-stable nitrogenous organic acid compositions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151593A1 (en) * 2001-04-13 2002-10-17 James Stitley Water-soluble creatine monohydrate formulations and process for their preparation
JP2003325114A (en) * 2002-05-14 2003-11-18 Dai Ichi Kogyo Seiyaku Co Ltd Coating agent for oral ingestion product
JP2003300885A (en) * 2003-06-24 2003-10-21 Meiji Seika Kaisha Ltd Antibacterial pharmaceutical composition
JP2007039408A (en) * 2005-08-05 2007-02-15 Unitec Foods Co Ltd Pulverized creatine and method for producing the same
JP2007131609A (en) * 2005-11-11 2007-05-31 Bhn Kk Composition for reinforcing endurance, preventing or recovering fatigue, or strengthening nourishment
JP2008184385A (en) * 2007-01-26 2008-08-14 Ezaki Glico Co Ltd Dispersed hesperetin
WO2019079651A1 (en) * 2017-10-18 2019-04-25 Glanbia Nutritionals (Ireland) Ltd. Shelf-stable nitrogenous organic acid compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023242126A1 (en) * 2022-06-14 2023-12-21 Alzchem Trostberg Gmbh Water-soluble creatine agglomerate

Also Published As

Publication number Publication date
JP7089278B2 (en) 2022-06-22

Similar Documents

Publication Publication Date Title
US7303765B2 (en) Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
JP6239579B2 (en) Carnitine granules and method for producing the same
JP5757493B1 (en) Solid composition for oral iron supplementation and method for producing the same
JP2014501530A (en) Nutritional supplements containing calcium beta-hydroxy-betamethylbutyrate and conjugated linoleic acid
EP3398591B1 (en) Microencapsulation of beta-alanine
WO2012133658A1 (en) Bottled beverage comprising cap containing dietary supplement and bottle filled with dispersion medium for dietary supplement
EP2822402A1 (en) Liquid nutritional composition comprising free amino acids
JP4215377B2 (en) Chitosan-containing composition
CN106420629A (en) Branched chain amino acid preparation and preparation method and application thereof
JP2004242509A (en) Food containing coenzyme q10 and amino acid
CA2867701C (en) Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles
JP2001031590A (en) Production and use of coated preparation
JP7089278B2 (en) Creatine-containing water-dispersible powdery composition and its production method
JP5418125B2 (en) Oral composition
JP2015514119A (en) Wet granulation method and granular material containing gum arabic
JP2014103872A (en) Jelling composition
ES2384577T3 (en) Coated Granular Formulations
JP3419729B2 (en) Tablet and method for producing the same
JP2019180350A (en) 3-hydroxyisovaleric acid-containing composition and method for producing the same
JP2016131501A (en) Coated granular composition
AU2016254983A1 (en) Monensin water dispersible granules by wet granulation
JP2021003024A (en) Sustained release covered food powder aggregate, and method for producing the same
JP2005008640A (en) Composition suppressing unpleasant taste of ingredient having unpleasant taste
JP2014114226A (en) Microencapsulated pharmaceutical preparation, production method thereof and liquid internal agent
JP2004075594A (en) Turmeric composition for oral administration

Legal Events

Date Code Title Description
RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20210129

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210420

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220414

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220511

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220603

R150 Certificate of patent or registration of utility model

Ref document number: 7089278

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150